CNBC’s Jim Cramer delivers his daily Mad Dash.

As climate change brings longer droughts, more frequent heat waves and increasingly unpredictable growing conditions to ...

Explore the revolutionary potential of biotechnology and gene editing, alongside crucial ethical considerations and ...

In South San Francisco, Genentech showed that recombinant DNA technology could transform medicine and create therapies once ...

July 6 (Reuters) - Morgan Stanley said the recent weakness in U.S. semiconductor stocks is a sign that the market gains are broadening, with investors likely to turn toward AI "hyperscalers" as well ...

Morgan Stanley says U.S. equity-market leadership is beginning to expand beyond the semiconductor and AI infrastructure ...

As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Novartis AG NVS has agreed to acquire privately held U.K. biotechnology company Myricx Bio in a deal valued at up to $1.5 ...

A Congressional investigation is looking into whether drug trials in China that involved U.S. companies possibly took place ...

David Craig’s operating manual for building biotech companies in today’s market is now available in hardcover and as an ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...